Article Details

Arrowhead doses first patient in Phase I/IIa RNA obesity therapy trial - Clinical Trials Arena

Retrieved on: 2024-12-24 19:54:29

Tags for this article:

Click the tags to see associated articles and topics

Arrowhead doses first patient in Phase I/IIa RNA obesity therapy trial - Clinical Trials Arena. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Arrowhead Pharmaceuticals Inc · Novo Nordisk AS · Eli Lilly and ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo